DE2927352A1
(de)
|
1979-07-06 |
1981-02-05 |
Thomae Gmbh Dr K |
In 6-stellung substituierte benzothiazol-2(3h)-one enthaltende arzneimittel
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
GB8817743D0
(en)
|
1988-07-26 |
1988-09-01 |
Fujisawa Pharmaceutical Co |
Fr901228 substance & preparation thereof
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
US5817667A
(en)
*
|
1991-04-17 |
1998-10-06 |
University Of Georgia Research Foudation |
Compounds and methods for the treatment of cancer
|
JPH064872A
(ja)
|
1992-06-19 |
1994-01-14 |
Sony Corp |
光ディスク再生装置
|
JPH0764872A
(ja)
|
1993-08-26 |
1995-03-10 |
Fujitsu Ten Ltd |
データ記憶制御装置
|
US5578832A
(en)
|
1994-09-02 |
1996-11-26 |
Affymetrix, Inc. |
Method and apparatus for imaging a sample on a device
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
US5776905A
(en)
|
1996-08-08 |
1998-07-07 |
The Board Of Trustees Of The Leland Stamford Junior University |
Apoptotic regression of intimal vascular lesions
|
US6030961A
(en)
|
1997-03-11 |
2000-02-29 |
Bar-Ilan Research & Development Co., Ltd. |
Oxyalkylene phosphate compounds and uses thereof
|
US6124495A
(en)
|
1997-03-11 |
2000-09-26 |
Beacon Laboratories, Inc. |
Unsaturated oxyalkylene esters and uses thereof
|
JP3494624B2
(ja)
|
1997-09-02 |
2004-02-09 |
住友製薬株式会社 |
新規な環状テトラペプチド誘導体とその医薬用途
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
JPH11335375A
(ja)
|
1998-05-20 |
1999-12-07 |
Mitsui Chem Inc |
ヒストン脱アセチル化酵素阻害作用を有するベンズアミド誘導体
|
US6214986B1
(en)
|
1998-10-07 |
2001-04-10 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of bcl-x expression
|
US20070148228A1
(en)
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US6723338B1
(en)
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
WO2001018171A2
(en)
|
1999-09-08 |
2001-03-15 |
Sloan-Kettering Institute For Cancer Research |
Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
|
EP1246839B1
(en)
|
1999-12-08 |
2004-06-16 |
Xcyte Therapies, Inc. |
Depsipeptide and congeners thereof for use as immunosuppressants
|
US6828302B1
(en)
|
1999-12-08 |
2004-12-07 |
Xcyte Therapies, Inc. |
Therapeutic uses of depsipeptides and congeners thereof
|
CA2317003A1
(en)
|
2000-02-28 |
2001-08-28 |
Hidenori Nakajima |
Gene expression potentiator
|
JP2001348340A
(ja)
|
2000-06-07 |
2001-12-18 |
Yamanouchi Pharmaceut Co Ltd |
ヒストン脱アセチル化酵素阻害剤
|
EP1302476B1
(en)
|
2000-07-17 |
2009-03-11 |
Astellas Pharma Inc. |
Reduced fk228 and use thereof
|
AU2001285042A1
(en)
|
2000-08-18 |
2002-03-04 |
The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
|
JP2004508049A
(ja)
|
2000-09-01 |
2004-03-18 |
藤沢薬品工業株式会社 |
Fr901228物質の製造法
|
AU2002243231A1
(en)
|
2000-11-21 |
2002-07-24 |
Wake Forest University |
Method of treating autoimmune diseases
|
WO2002055688A2
(en)
|
2001-01-10 |
2002-07-18 |
Us Gov Health & Human Serv |
Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
|
US7219016B2
(en)
|
2001-04-20 |
2007-05-15 |
Yale University |
Systems and methods for automated analysis of cells and tissues
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
DE60227658D1
(de)
|
2001-05-02 |
2008-08-28 |
Univ California |
Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
|
AU2002305769B2
(en)
|
2001-05-30 |
2007-07-19 |
Georgetown University |
Small molecule antagonists of Bcl2 family proteins
|
US7171311B2
(en)
|
2001-06-18 |
2007-01-30 |
Rosetta Inpharmatics Llc |
Methods of assigning treatment to breast cancer patients
|
HU229521B1
(hu)
|
2001-08-21 |
2014-01-28 |
Astellas Pharma Inc |
A hiszton-dezacetiláz inhibitor gyógyászati alkalmazása, és eljárás tumorellenes hatásának kiértékelésére
|
WO2003017763A1
(en)
|
2001-08-24 |
2003-03-06 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
|
EP1293205A1
(en)
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
US6706686B2
(en)
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
AU2002353891A1
(en)
|
2001-10-25 |
2003-05-06 |
Buck Institute For Age Research |
Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
|
WO2003038060A2
(en)
|
2001-11-01 |
2003-05-08 |
The Regents Of The University Of Michigan |
Small molecule inhibitors targeted at bcl-2
|
WO2003053468A1
(en)
|
2001-12-21 |
2003-07-03 |
Universite Libre De Bruxelles |
Method for obtaining the elimination of integrated and functional viruses from infected mammal cells
|
US20030134423A1
(en)
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
JP2005525345A
(ja)
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Trx媒介性疾患を処置する方法
|
WO2003070754A1
(fr)
|
2002-02-20 |
2003-08-28 |
Minoru Yoshida |
Inhibiteurs d'histone desacetylase et procede de production de ces inhibiteurs
|
US20040132825A1
(en)
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
NZ567758A
(en)
|
2002-03-04 |
2009-07-31 |
Merck Hdac Res Llc |
Methods of inducing terminal differentiation using suberoylanilide hydrozmic acid (SAHA)
|
AU2003226014A1
(en)
|
2002-03-28 |
2003-10-13 |
Brigham And Women's Hospital, Inc. |
Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
|
CN1649645A
(zh)
|
2002-04-05 |
2005-08-03 |
藤泽药品工业株式会社 |
用于治疗肾癌的缩酚肽
|
AU2003226408B2
(en)
|
2002-04-15 |
2007-06-14 |
Sloan-Kettering Institute For Cancer Research |
Combination therapy for the treatment of cancer
|
US6809118B2
(en)
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
US20040002447A1
(en)
|
2002-06-04 |
2004-01-01 |
Regents Of The University Of California |
Induction of insulin expression
|
US20050065596A1
(en)
|
2002-07-24 |
2005-03-24 |
Xufan Tseng |
Stents capable of controllably releasing histone deacetylase inhibitors
|
ES2342378T3
(es)
|
2002-08-20 |
2010-07-06 |
Astellas Pharma Inc. |
Inhibidor de degradacion de matriz extracelular del cartilago artrodial.
|
BR0314112A
(pt)
|
2002-09-13 |
2005-07-12 |
Univ Virginia Commonwealth |
Combinação de a) n-{5-[4-(4-metil-piperazino-metil)-benzoilamido]-2-metil fenil}-4-(3-piridil)-2-pirimidina-amina e b) um inibidor de desacetilase de histona para o tratamento de leucemia
|
SE0300098D0
(sv)
|
2003-01-15 |
2003-01-15 |
Forskarpatent I Syd Ab |
Use of cyclin D1 inhibitors
|
WO2004064727A2
(en)
|
2003-01-16 |
2004-08-05 |
Georgetown University |
Method of cancer treatment using hdac inhibitors
|
KR20050106438A
(ko)
|
2003-02-19 |
2005-11-09 |
아스텔라스세이야쿠 가부시키가이샤 |
히스톤 디아세틸라제 저해제의 항종양 효과의 예측방법
|
WO2004096289A1
(ja)
|
2003-04-25 |
2004-11-11 |
Fujisawa Pharmaceutical Co |
遺伝子導入効率増強剤
|
US20040213826A1
(en)
|
2003-04-28 |
2004-10-28 |
Marx Steven O. |
Medical devices and methods for inhibiting proliferation of smooth muscle cells
|
EP1491188A1
(en)
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
PL2238982T3
(pl)
|
2003-06-27 |
2013-03-29 |
Astellas Pharma Inc |
Środek do terapii mięsaka tkanek miękkich
|
BR122016015715B8
(pt)
|
2003-07-23 |
2021-05-25 |
Bayer Healthcare Llc |
composições farmacêuticas de metilamida de ácido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenóxi)-piridina-2-carboxílico
|
AU2003268185A1
(en)
*
|
2003-08-25 |
2005-04-11 |
Dana-Farber Cancer Institute Inc. |
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
|
AU2004266169B9
(en)
|
2003-08-26 |
2007-05-10 |
Merck Hdac Research, Llc |
Method of treating cancer with HDAC inhibitors
|
EP2226072A1
(en)
|
2003-08-29 |
2010-09-08 |
Aton Pharma, Inc. |
Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer
|
US20050059682A1
(en)
|
2003-09-12 |
2005-03-17 |
Supergen, Inc., A Delaware Corporation |
Compositions and methods for treatment of cancer
|
KR20070012618A
(ko)
|
2003-09-18 |
2007-01-26 |
콤비네이토릭스, 인코포레이티드 |
신생물 치료용 약의 조합
|
DE602004027824D1
(de)
|
2003-09-25 |
2010-08-05 |
Astellas Pharma Inc |
Antitumorales mittel mit einem histon-deacetylase-hemmer und einem topoisomerase-ii-hemmer
|
US8614318B2
(en)
|
2003-11-13 |
2013-12-24 |
Abbvie Inc. |
Apoptosis promoters
|
JP2007511211A
(ja)
|
2003-11-14 |
2007-05-10 |
ホルム,ペル・ゾンネ |
アデノウイルスおよびそれをコードしている核酸の新たな使用
|
CA2590257A1
(en)
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
|
WO2005053609A2
(en)
|
2003-11-26 |
2005-06-16 |
Guilford Pharmaceuticals Inc. |
Methods of nad+-dependent deacetylase inhibitors
|
WO2005058298A2
(en)
|
2003-12-10 |
2005-06-30 |
Wisconsin Alumni Research Foundation |
Fk228 analogs and their use as hdac-inhibitors
|
US7951780B2
(en)
|
2004-02-25 |
2011-05-31 |
Astellas Pharma Inc. |
Antitumor agent
|
US20050187148A1
(en)
|
2004-02-25 |
2005-08-25 |
Yoshinori Naoe |
Antitumor agent
|
CA2557568C
(en)
|
2004-02-27 |
2014-05-27 |
Jane Trepel |
Pharmacodynamic assays using flow cytometry
|
GB0405349D0
(en)
|
2004-03-10 |
2004-04-21 |
Univ Birmingham |
Cancer therapy and medicaments therefor
|
PL1591109T3
(pl)
|
2004-04-30 |
2008-11-28 |
Topotarget Germany Ag |
Preparat zawierający inhibitor deacetylazy histonów wykazujący dwufazowe uwalnianie”
|
ITMI20040876A1
(it)
|
2004-04-30 |
2004-07-30 |
Univ Degli Studi Milano |
Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
|
WO2005115149A2
(en)
|
2004-05-20 |
2005-12-08 |
Dow Agrosciences Llc |
Insectidal activity of a cyclic peptide
|
WO2005117930A2
(en)
|
2004-06-04 |
2005-12-15 |
Sloan-Kettering Institute For Cancer Research |
Use of thioredoxin measurements for diagnostics and treatments
|
WO2005123089A2
(en)
|
2004-06-10 |
2005-12-29 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
US20060018921A1
(en)
|
2004-07-16 |
2006-01-26 |
Baylor College Of Medicine |
Histone deacetylase inhibitors and cognitive applications
|
US7745446B2
(en)
|
2004-09-06 |
2010-06-29 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolo[1,5-c]pyrimidines
|
CA2586228A1
(en)
|
2004-11-17 |
2006-05-26 |
The University Of Chicago |
Histone deacetylase inhibitors and methods of use
|
US8889742B2
(en)
|
2004-11-30 |
2014-11-18 |
The Trustees Of The University Of Pennsylvania |
Use of HDAC and/or DNMT inhibitors for treatment of ischemic injury
|
WO2006060429A2
(en)
|
2004-12-03 |
2006-06-08 |
Novartis Ag |
Identification of variants in histone deacetylase 1 (hdac1) to predict drug response
|
US20060128660A1
(en)
|
2004-12-10 |
2006-06-15 |
Wisconsin Alumni Research Foundation |
FK228 analogs and methods of making and using the same
|
GB0511266D0
(en)
|
2005-06-02 |
2005-07-13 |
Trust |
Chemical compounds
|
EP1743654A1
(en)
|
2005-07-15 |
2007-01-17 |
TopoTarget Germany AG |
Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases
|
US7943568B2
(en)
|
2005-09-30 |
2011-05-17 |
The Ohio State University Research Foundation |
Antitumor agents
|
JP2009515524A
(ja)
|
2005-11-10 |
2009-04-16 |
アメリカ合衆国 |
Abcb1多型バリアントスクリーニング、診断及び処置のための物質及び方法
|
EP1965824A4
(en)
|
2005-11-18 |
2011-10-19 |
Gloucester Pharmaceuticals Inc |
METABOLITENE DERIVATIVES OF HDAC INHIBITOR FK228
|
EP2049139A4
(en)
|
2006-04-24 |
2009-06-24 |
Gloucester Pharmaceuticals Inc |
TREATMENT OF TUMORS EXPRESSING RAS
|
US8957027B2
(en)
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
JP2009539862A
(ja)
|
2006-06-09 |
2009-11-19 |
メリオン リサーチ Iii リミテッド |
強化剤を含む固体経口投与剤形
|
US7857804B2
(en)
|
2006-09-01 |
2010-12-28 |
Mccaffrey Timothy A |
Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders
|
US20100093610A1
(en)
*
|
2006-12-29 |
2010-04-15 |
Vrolijk Nicholas H |
Romidepsin-based treatments for cancer
|
MX2009006969A
(es)
|
2006-12-29 |
2010-04-07 |
Gloucester Pharmaceuticals |
Purificacion de romidepsina.
|
WO2009064300A1
(en)
*
|
2007-11-15 |
2009-05-22 |
The Johns Hopkins University |
Combinations of hdac inhibitors and cytokines/growth factors
|
MX2011001132A
(es)
*
|
2008-07-30 |
2011-08-17 |
Gloucester Pharmaceuticals Inc |
Tratamiento acelerado.
|